Related by context. All words. (Click for frequent words.) 76 Ophthalmic Drugs Advisory 75 Drugs Advisory 74 FDA Pulmonary Allergy 74 FDA Dermatologic 73 Arthritis Advisory 72 Antiviral Drugs Advisory 71 Oncologic Drugs Advisory 70 FDA Endocrinologic 70 FDA Advisory Panel 69 Anti Infective Drugs 69 FDA Oncologic Drugs 68 Metabolic Drugs Advisory 68 Metabolic Drugs 66 Pulmonary Allergy Drugs 65 PDUFA Date 65 FDA Approvable Letter 65 Psychopharmacologic Drugs Advisory 64 Resubmission 63 Renal Drugs Advisory 63 lucinactant 62 FDA Psychopharmacologic Drugs 62 Endocrinologic 62 Nonprescription Drugs Advisory 62 Faropenem 62 See CLINICAL PHARMACOLOGY 62 guanfacine extended release 62 Drug Administration Oncologic Drugs 61 AIDAC 61 Pivotal Phase III 61 Neurological Devices 61 FDA Antiviral Drugs 61 Romiplostim 61 Ranolazine 61 Coadministration 61 Tezampanel 60 Fulvestrant 60 Ocrelizumab 60 Nonprescription Drugs 60 Potent Antiviral Activity 60 carbamazepine phenobarbital phenytoin rifampin 60 Drug Administration FDA Oncologic 60 Devices Advisory Panel 60 Phase III Clinical Trials 60 Novel Antibiotic 60 Ondansetron Injection USP 60 Lubiprostone 60 Expanded Indication 60 LibiGel ® 60 Biological Effects 59 Complicated Skin 59 Emollient Foam 59 Eszopiclone 59 Intravenous Formulation 59 Complete Response Letter CRL 59 Telavancin 59 Arch Neurol 59 Fondaparinux 59 Mg Usa 59 Final Appraisal Determination 59 Antithrombotic 59 STELARA TM 59 Keryx Biopharma 59 GTC recombinant form 59 FOLOTYN ® 59 Panzem R 59 Oral Calcitonin 59 FDA Nonprescription Drugs 59 PRNewswire FirstCall Genta Incorporated 59 investigational antiplatelet agent 59 Drug Administration FDA Endocrinologic 59 Regeneron Pharma 59 Auxilium Pharma 59 Therapeutic Approaches 59 Aromatase Inhibitors 59 Human Medicinal Products 59 Mylan Receives Approval 59 Pooled Analysis 59 Clinical Trial Results 58 FDA Accepts 58 Poster Discussion 58 Kidney Transplant Patients 58 Not Approvable 58 Hormone Refractory Prostate Cancer 58 Kuvan sapropterin dihydrochloride 58 Known hypersensitivity 58 Meets Primary Endpoint 58 Long Term Efficacy 58 Second Pivotal Phase 58 Clinical Efficacy 58 oral dual endothelin 58 Prolongs Survival 58 Anidulafungin 58 Investigational Drug 58 Fast Track Status 58 VIVITROL ® 58 Pivotal Clinical Trial 58 Injection Site 58 Act PDUFA date 58 Immunogenicity 58 Adjuvant Treatment 58 NASDAQ AVNR 58 Complete Response 58 Antiplatelet 58 Pirfenidone 58 Pegloticase 58 liver resection surgeries 58 Arch Dermatol 58 balsalazide disodium Capsules 58 FDA Circulatory System 58 Brentuximab Vedotin SGN 58 iloprost Inhalation Solution 58 prucalopride 58 SWX BSLN 58 European Medicines Evaluation 58 containing granisetron 58 FDA Oncologic Drug 57 Prospective Randomized 57 Tesamorelin 57 Seasonal Influenza Vaccine 57 PRAECIS PHARMACEUTICALS INCORPORATED 57 IL# PE#QQR 57 Febuxostat 57 Arthritis Drugs 57 Phase 2a Trial 57 Diabet Med 57 NASDAQ BDSI 57 FUSILEV ® 57 Afinitor everolimus 57 Sanofi aventis EURONEXT SAN 57 Vitrasert R 57 FDA approvable letter 57 Novel Therapies 57 vapreotide acetate 57 Zarnestra 57 aripiprazole Abilify 57 Vion Pharmaceuticals 57 Renal Impairment 57 Inflammatory Arthritis 57 ibuprofen Injection 57 TORISEL TM 57 Ticagrelor 57 Hematologic Oncology 57 Dalbavancin 57 Neoadjuvant Chemotherapy 57 Investigational Compound 57 TYGACIL 57 Tigecycline 57 Generic Versions 57 Phase 2b Study 57 methylnaltrexone bromide 57 Dietetic Products 57 NASDAQ CXSP announced 57 Anti Angiogenic 57 TOPAMAX R 57 Marketing Authorisation Application 57 Oracea TM 57 adalimumab Humira 57 FDA Complete Response 57 Phase III Clinical Trial 57 CRMD# 57 OSMOPREP TM 57 Dermatologic 57 Demonstrates Efficacy 57 Radiological Devices 57 Submits NDA 57 Renal Cell Carcinoma 57 Clinical Trial Data 57 Urinary Incontinence 57 Hematologic 57 Free Full Text 57 Anti Inflammatory Drug 57 Cethromycin 57 Dementia Related Psychosis 57 brivaracetam 57 rasagiline tablets 57 myelodysplastic myeloproliferative diseases 57 Ramelteon 57 Medicinal Products EMEA 57 Afatinib 57 Belimumab 57 Suicidality 57 Molecular Cancer 57 NIH Consensus 57 Telbivudine 57 Obes Res 57 Phase IIb Trial 57 Lilly Cymbalta 57 FDA APPROVES 57 Sprycel dasatinib 57 Diabetic Nephropathy 57 Immune Mediated 56 Nasdaq DVAX 56 Generic Version 56 Gout Drug 56 CERVARIX R 56 Erectile Dysfunction Drug 56 Clinical Practice Guideline 56 Itraconazole 56 Marketing Authorisation Application MAA 56 Hepatotoxicity 56 DORIBAX 56 NASDAQ ISTA 56 Safinamide 56 Rebif ® 56 Therapeutic Potential 56 Adalimumab 56 Myelodysplastic Syndromes 56 Low Dose 56 Bepreve TM 56 Tumor Response 56 CYP#A# substrate 56 Vandetanib 56 Prostate Cancer Vaccine 56 Single Dose 56 Serdolect ® 56 Receives Approvable Letter 56 XGEVA ™ 56 Bazedoxifene 56 IND Application 56 Extended Release 56 Rheumatoid Arthritis Drug 56 HER2 Positive 56 Biologic License Application 56 J Am Acad 56 Treating Chronic 56 Raptiva R 56 Bifeprunox 56 Rotavirus Vaccines 56 interferon gamma 1b 56 Proprietary Medicinal Products CPMP 56 Extina 56 Cholesterol Lowering Drug 56 NDA Submission 56 specifically hypoactive sexual 56 Inflammatory Markers 56 Androxal ® 56 Epilepsy Drug 56 Acute Ischemic Stroke 56 Inc. OTCBB VODG 56 Glatiramer Acetate 56 Gastrointestinal GI 56 Phase III Trials 56 Accelerated Approval 56 Avastin bevacizumab 56 alvimopan 56 Hematological 56 Inflammatory Diseases 56 Investigational Drugs 56 Risperidone Oral Solution 56 ORENCIA ® 56 Liprotamase 56 sapropterin dihydrochloride 56 Mycophenolate Mofetil 56 levetiracetam Keppra 56 ARCOXIA 56 Nexavar sorafenib 56 Aztreonam Lysine 56 BioSante Pharmaceuticals Reports 56 Eculizumab 56 Tasigna nilotinib 56 Zorbtive TM 56 Gel repository corticotropin injection 56 Cardiovascular Outcomes 56 PROVENGE ® 56 Peginterferon alfa 2b 56 Bioequivalence 56 Investigational Agent 56 Interferon Beta 56 Injectafer 56 RhuDex 56 QLT# 55 Supplemental Biologics License Application 55 octreotide acetate 55 mesylate tablets 55 INSPIRE Trial Phase III 55 Recommends Approval 55 Reminyl galantamine 55 sodium benzoate prescription 55 Augment ™ Bone Graft 55 CHMP recommendation 55 Nebulized 55 midstage clinical 55 Antitumor 55 Tekturna HCT 55 Teva Provides Update 55 PDUFA Prescription Drug 55 Mg Uk 55 Angiox ® 55 Liver Toxicity 55 Gastrointestinal Drugs 55 granted Ortec 55 Immunotherapeutic 55 Eurand NV EURX 55 PROTONIX 55 5 HT6 receptor 55 Hsp# Inhibitor 55 nasal calcitonin product 55 Soriatane 55 BLP# Liposome Vaccine 55 Placebo Controlled Trial 55 ALLSCHWIL BASEL SWITZERLAND 55 Golimumab 55 JAK Inhibitor 55 Drug Candidate 55 NASDAQ SHPGY 55 Testosterone MDTS ® 55 Lambert Eaton Myasthenic 55 Endocrine Practice 55 Sustained Efficacy 55 ANDA Filing 55 Femara letrozole 55 Calcitonin 55 indiplon capsules 55 J Am Coll 55 Product Monograph 55 Dasatinib 55 Pafuramidine 55 Announces Tentative Approval 55 Antifungals 55 ONGLYZA ™ 55 Phase III Trial 55 Approvable 55 Colorectal Cancer Patients 55 Topical Gel 55 Release Capsules 55 ONGLYZA TM 55 Am J Clin 55 selective modulator 55 LSE ASM 55 Toremifene 55 Paliperidone ER 55 Gastric Cancer 55 worsening thrombocytopenia 55 Focalin XR R 55 Investigational Treatment 55 VALSTAR 55 Ozarelix 55 Warfarin Coumadin 55 Talabostat 55 Inc. NASDAQ BPAX 55 Xelox 55 Oracea R 55 R metformin Concor 55 GATTEX TM 55 BAL# [002] 55 REPRONEX R menotropins 55 Biomarker Study 55 T Pred 55 Psoriasis Drug 55 ANTEGREN 55 capsules USP 55 pregabalin Lyrica 55 Mycamine 55 Clinical Trial Enrollment 55 Effectively Treats 55 ARIXTRA R 55 XIAFLEX TM 55 Silodosin 55 Application BLA 55 Intermezzo ® NDA 55 Initiates Enrollment 55 1mg 2mg 55 Positive Opinion 55 Maleate 55 acute onset CINV 54 AVASTIN 54 Paxil paroxetine 54 Ropinirole 54 Nasdaq OSCI 54 balsalazide tablet 54 Fibrin Sealant Human 54 Anti infective 54 Fludara ® 54 Bivalirudin 54 Hycamtin ® 54 Topical Cream 54 REVLIMID R 54 Dyloject TM 54 Tekturna HCT ® 54 GRAS Status 54 QNEXA 54 Amgen Nplate 54 Oracea ® 54 ASM Biodefense 54 Demonstrates Significant 54 pioglitazone HCl 54 FACTIVE tablets 54 MAGE A3 ASCI 54 sitaxsentan 54 Vidaza azacitidine 54 SPARLON 54 peginesatide 54 buccal tablets 54 Prostate Cancer Treatment 54 Personalized Immunotherapy 54 Lung Cancer Drug 54 Orexigen Contrave 54 Practice Guideline 54 Antiviral Drugs 54 RNAi Therapeutic 54 Proprietary Medicinal Products 54 GABITRIL 54 markets HP Acthar 54 Combination Treatment 54 Fewer Side Effects 54 M.D. Ph.D. 54 Anti Infectives 54 BioDelivery Sciences 54 Carbidopa Levodopa 54 Cimzia ® certolizumab pegol 54 Bicalutamide 54 Bare Metal Stent 54 Vaccine Immunology 54 Unfractionated Heparin 54 Antiepileptic Drugs 54 Velcade bortezomib 54 Loceryl ® 54 Marketing Authorisation 54 Granted Orphan Drug 54 Cerezyme Fabrazyme Myozyme Aldurazyme 54 Cinacalcet 54 Excretion 54 Celsion Corporation 54 SIX BSLN 54 Cimzia certolizumab pegol 54 FASLODEX 54 tazobactam 54 Meta Analysis 54 Gene Therapy Advisory 54 Dr. Gulfo 54 Rotavirus Vaccine 54 MOVIPREP R 54 Plastic Surgery Devices 54 Shows Efficacy 54 Int J Cancer 54 Esbriet ® 54 Ozurdex 54 Pemetrexed 54 nanofiltered plasma derived 54 SPRYCEL ® 54 Sodium Injection 54 CHMP 54 Monoclonal Antibodies 54 Renal Cancer 54 Multiple Myeloma Patients 54 Receives Orphan Drug 54 nitrofurantoin 54 INVEGA ® 54 Recombinant Human 54 TSX SHQ 54 azficel T 54 Complete Response letter 54 Benign Prostatic Hyperplasia 54 Chronic Inflammation 54 histamine dihydrochloride 54 Clin Chem 54 primary Restless Legs 54 include Alferon N 54 testosterone gel LibiGel 54 Alogliptin 54 Arch Pediatr Adolesc Med 54 oxymorphone ER 54 Potiga 54 Roche Actemra 54 Nasdaq ADLR 54 Patient Outcomes 54 MEDCAC 54 Inc. AMEX LIV 54 FACTIVE R gemifloxacin 54 Pre IND 54 Tekamlo 54 BRILINTA 54 Application MAA 54 Orphan Medicinal Products 54 oral rivaroxaban 54 CONBRIZA 54 Cancer Vaccines 54 Female Urology 54 Qutenza TM 54 AMMONUL R sodium phenylacetate 54 PLAVIX ® 54 Montelukast 54 ezogabine 54 Hospital Acquired Pneumonia 54 OMP designation 54 SEROQUEL XR 54 Cellular Tissue 54 Emezine 54 Anticancer Drug 54 Nabi HB Intravenous 54 Pivotal Trial 54 Propoxyphene 54 Slow Progression 54 DEXILANT 54 Xyrem ® 54 Vimpat R 54 DexaSite 54 Complete Response Letter 54 Inc. Nasdaq SNSS 53 efalizumab 53 Emezine R 53 Anemia Drug 53 Elestrin TM 53 Levofloxacin 53 QNEXA ® 53 Hepatitis B Vaccine 53 Nasdaq NYMX 53 Acute Heart Failure 53 RECOTHROM R 53 tocilizumab 53 sorafenib tablets 53 ISO Vorin TM 53 Improved Survival 53 Transdermal Patch 53 LYSTEDA 53 Treat Anemia 53 FDA Approvals 53 Serious Side Effects 53 NASDAQ INGN 53 Kinase Inhibitor 53 ULTRASE 53 hylan GF 53 abacavir sulfate lamivudine 53 Firdapse ™ amifampridine phosphate 53 Rasagiline 53 MOVIPREP ® 53 Human Use CHMP 53 BUPHENYL ® sodium phenylbutyrate 53 commercialize oritavancin 53 PROMACTA 53 Pharmacokinetic Profile 53 Valsartan 53 Pfizer Geodon 53 Oral Abstract 53 Shown Effective 53 Pulmonary Arterial Hypertension 53 Biologic License Application BLA 53 novel bactericidal 53 abatacept Orencia 53 GTC recombinant human 53 Prophylactic Treatment 53 Entereg R 53 SILENOR 53 Tracleer ® bosentan 53 Vitrasert ® 53 Lung Cancer Trial 53 SmPC 53 Survival Benefit 53 Cellegesic TM nitroglycerin ointment 53 European Medicines Agency 53 Dexilant 53 cytomegalovirus CMV retinitis 53 Clinical Evaluation 53 Hepatitis C Treatment 53 Celebrex celecoxib 53 Citizen Petition 53 Ambrisentan 53 Frovatriptan 53 DRUG ADMINISTRATION 53 Eribulin 53 Clinical Guideline 53 Bosutinib 53 conjugated estrogens 53 Therapeutic Targets 53 Shows Promise Against 53 Gastrointestinal Disorders 53 Plicera 53 Epidermal Growth Factor Receptor 53 ZEGERID Chewable Tablets 53 Crit Rev 53 Subtypes 53 RNAi Therapeutics 53 Severe Sepsis 53 Elvitegravir 53 Azacitidine 53 mesylate 53 Calcium Acetate 53 Moxifloxacin 53 pancreatic enzyme replacement 53 Severe Asthma 53 Vitro Diagnostic Device 53 Medoxomil 53 REBETOL combination therapy 53 Endeavor Drug Eluting 53 Analgesic 53 REYATAZ R 53 SHP.L 53 REVLIMID lenalidomide 53 Premarket Approval PMA 53 Arzerra ofatumumab 53 Atomoxetine 53 dual endothelin receptor antagonist 53 Vaccine Diphtheria CRM# Protein 53 Diabetes Digestive 53 journal Arteriosclerosis Thrombosis 53 miconazole Lauriad ® 53 ALVESCO R 53 Clinical Practice Guidelines 53 AZILECT R 53 RAPAMUNE 53 Multicenter Study 53 Noxafil 53 desvenlafaxine 53 Advanced Renal Cell 53 Raptiva ® 53 developer Antisoma plc 53 Actelion Ltd 53 desire disorder HSDD 53 Nymox NX 53 CERVARIX 53 SUPPRELIN R LA 53 Drug Eluting Stent System 53 Neupro R 53 Silenor ® doxepin 53 Expert Advisory Panel 53 BYETTA ® 53 Posaconazole 53 Betaferon R 53 Adentri 53 RANK Ligand inhibitor 53 Eraxis 53 Pivotal Study 53 opioid narcotic 53 pseudobulbar affect PBA 53 refractory chronic lymphocytic 53 Product Characteristics 53 Novel Small Molecule 53 PRISTIQ 53 SUTENT ® 53 ASGCT 53 supplemental Biologics License Application 53 Cancer Immunotherapy 53 R sipuleucel T 53 Anticoagulant 53 Marketing Authorization Application 53 Invasive Fungal Infections 53 Resurgex Plus 53 Elan NanoCrystal 53 TEMODAL 53 approvability 53 Pre Eclampsia 53 rHuPH# recombinant human 53 Muraglitazar 53 DASISION study 53 GARDASIL ® 53 Nasdaq BDSI 53 Approvable Letter 53 Scientific Advice 52 Randomized Clinical Trial 52 Zometa zoledronic acid 52 Clinical Outcome 52 Lenalidomide 52 approvable letters 52 Vyvanse lisdexamfetamine dimesylate 52 Metabolic Disorders 52 AVAPRO 52 severe hypercholesterolemia 52 Vector Borne 52 Hematologic Malignancies 52 Antiviral 52 Blood Thinning 52 Immunisation Practices 52 Darunavir 52 Milnacipran 52 Biosimilar 52 Deferiprone 52 NEUPOGEN 52 Alitretinoin 52 TYKERB 52 Improve Diagnosis 52 highly purified pasteurized 52 TYZEKA 52 Rasilamlo 52 Detection Evaluation 52 Hepatocellular Carcinoma 52 Dupuytren Contracture 52 Ophthalmic Drug 52 Gynecol Oncol 52 Update Advisory MDKSA 52 norfloxacin 52 fondaparinux sodium 52 Besivance 52 Peptic Ulcer 52 AstraZeneca Symbicort 52 Azathioprine 52 Neuropathic Pain 52 Zytiga 52 balsalazide 52 Ixempra 52 By JAMAAL ABDUL 52 Recombinant DNA Advisory 52 CYP#A# inhibitor 52 Multaq dronedarone 52 Saizen ® 52 gadobutrol 52 Methylnaltrexone 52 Files IND 52 Hexvix 52 metformin HCl 52 Allergic Rhinitis 52 Adenoma 52 Malignant Melanoma 52 Pegintron 52 Haemophilus b Conjugate 52 Biologics Licensing 52 Lamotrigine 52 Chromium Picolinate 52 haloperidol Haldol 52 sNDA submission 52 SEROQUEL R 52 ofatumumab HuMax CD# 52 Marketing Authorization Applications 52 Xarelto rivaroxaban 52 ketolide antibiotic 52 Schizophrenia Treatment 52 MERIT ES 52 Carbamazepine 52 Medicinal Products 52 Receives Orphan Drug Designation 52 ZEGERID Capsules 52 Vernakalant 52 Clofarabine 52 Mirapexin 52 Focetria 52 Immune Globulin Human 52 Dabigatran etexilate 52 Restoraderm R 52 EMPOWER ™ 52 Reverse Transcriptase 52 Novel Vaccine 52 piroxicam 52 Antifungal 52 Pharmacoepidemiology 52 PDUFA date 52 Zenpep 52 NAVISTAR R 52 Arterial Hypertension 52 Recombinant DNA 52 levocetirizine 52 Drug Formulation 52 MAA submission 52 Levels Linked 52 DAYTRANA TM 52 danazol 52 Metastatic Colorectal Cancer 52 Syndrome LEMS 52 alfuzosin 52 Mimetics 52 tazarotene 52 Eur Urol 52 Pre Filled Syringes 52 LymphoStat B TM 52 Aloprim TM allopurinol sodium 52 Estrogen Receptor 52 Celgene Revlimid 52 NOXAFIL 52 Cilostazol 52 Jevtana 52 Targanta Therapeutics 52 Nutrition SACN 52 Beta Blocker 52 Nasdaq NABI 52 Receives Positive Opinion 52 Slows Progression 52 SCHWARZ PHARMA 52 Clevudine 52 Quadrivalent 52 Frova ® 52 rivastigmine Exelon 52 Multidrug 52 Community Acquired Pneumonia 52 hypereosinophilic syndrome 52 YONDELIS R 52 SNT-MC#/idebenone 52 application sNDA 52 INVIRASE 52 Clolar ® 52 Dificid 52 tramiprosate ALZHEMED TM 52 AVANDIA 52 Post Operative 52 sNDA 52 Smooth Muscle 52 Diagnosis Treatment 52 paroxetine Paxil 52 HFA MDI 52 Teriparatide 52 Orapred ODT 52 Nasdaq ENCY 52 Rhucin ® recombinant 52 submitted supplemental Biologics 52 Tiotropium 52 Augment ™ 52 ZOLINZA 52 Doribax 52 BENECOL R Spreads 52 Fablyn 52 ATACAND 52 NYSE Amex PTN 52 Gilenia 52 Exelon rivastigmine 52 multicenter randomized Phase III 52 Ionizing Radiation 52 Combunox 52 Schizophrenia Drug 52 Kynapid 52 risedronate sodium tablets 52 antidiabetic drug 52 Losartan Potassium 52 Ceftobiprole 52 ORENCIA R 52 Zyflo 52 Chronic Hepatitis B 52 Fabry Disease 52 Antipsychotic 52 Involuntary Exposure 52 Cetrorelix 52 Begin Clinical Trials 52 solifenacin succinate 52 Natroba 52 Expedited Review 52 balsalazide disodium 52 Eli Lilly Cymbalta 52 Vertex hepatitis C 52 fluoroquinolone antibiotic 52 CIMZIA ® 52 Research CBER 52 See CONTRAINDICATIONS 52 Advagraf 52 rotigotine transdermal patch 52 daptomycin 52 Veregen TM 52 Biochemical Pharmacology 52 ARIXTRA 52 User Requirements 52 Teikoku Pharma USA 52 Miconazole 52 Submits Response 52 Amlodipine Besylate Tablets 52 Desvenlafaxine 52 Epiduo 52 Receives Complete Response 52 Sanctura XR 52 Overactive Bladder 52 paliperidone palmitate 52 autologous cellular immunotherapy 52 Outcomes Research ISPOR 52 Arpida 52 Aryplase 52 Microspheres 52 Flutiform ™ 52 Ranexa R 52 ZIANA TM 52 index assay IVDMIA 51 Eloxatin ® 51 cetuximab Erbitux 51 Mucosal 51 Ziprasidone 51 Famotidine 51 Ohr Pharmaceutical Inc. 51 EMBEDA ™ 51 Metabolic Endocrinology 51 acyclovir Lauriad R 51 Torisel temsirolimus 51 International Nonproprietary Name 51 Luveris 51 NUEDEXTA ™ 51 Nebulized Formoterol 51 Improves Outcomes 51 Significant Reduction 51 Pediatric Patients 51 Topiramate 51 Tablets #mg [001] 51 Osteoporosis Treatment 51 Sustained Release 51 #mg #mg #mg #mg [002] 51 k Premarket Notification 51 Treanda bendamustine 51 Gamunex C 51 Corticosteroid 51 Recombinant Protein 51 BioElectronics Announces 51 Sutent sunitinib malate 51 Junovan 51 Cardiometabolic 51 Irinotecan 51 Gonal f ® 51 Acute Treatment 51 Developmental Therapeutics Immunotherapy 51 Postmenopausal Osteoporosis 51 sertraline Zoloft 51 Medicines CSM 51 DASISION 51 anakinra 51 Didanosine 51 Wyeth Torisel 51 abacavir sulfate 51 anidulafungin 51 Stavzor 51 Paliperidone Palmitate 51 Sitagliptin 51 Iressa gefitinib 51 Topical Treatment 51 rheumatoid arthritis psoriatic arthritis 51 Taxotere ® 51 Exforge HCT 51 MEVACOR 51 Vertex telaprevir 51 Vioxx Successor 51 Board DSMB 51 Novartis Trileptal 51 Protease Inhibitors 51 Bayer Xarelto 51 #:#-# [029] 51 Clinical Trial Evaluating 51 Arzerra TM 51 Yondelis ® 51 Rivaroxaban 51 Fluconazole 51 Therapeutic Agents 51 Orphan Status 51 #D#C# 51 Javelin Pharmaceuticals AMEX JAV 51 Inhalation Aerosol 51 Therapeutic Vaccine 51 Accelerated Assessment 51 recombinant thrombin 51 diarrhea predominant irritable 51 estradiol gel 51 Muscle Wasting 51 Firdapse TM amifampridine phosphate 51 Directorate TPD 51 Luvox fluvoxamine 51 dose proportionality 51 Expert Opin 51 Sparlon 51 Cannabinoid 51 BENLYSTA ® 51 Inhaled Insulin 51 Focalin XR 51 ADVANCE PD 51 zolpidem tartrate sublingual tablet 51 Ceflatonin ® 51 Prestara TM 51 DOXIL 51 Anti Infective 51 Atypical Antipsychotic 51 LSE SHP.L 51 Xolegel 51 Genetic Manipulation 51 EFSA Panel 51 Intervention Trial GAIT 51 Aztreonam 51 Lipid Lowering 51 Pharmacodynamics 51 Postdoctoral Position 51 Pesticide Residues 51 treat atrial flutter 51 Astelin 51 SYCREST 51 Frova R 51 Neulasta ® 51 barbiturates benzodiazepines 51 Onrigin 51 Xinlay 51 framers Bahaa al Araji 51 LSE SHP NASDAQ SHPGY 51 RIGScan ™ 51 Radiation Treatment 51 broad spectrum cephalosporin 51 Food Additives JECFA 51 Ropren 51 reduce serum phosphate 51 Exp Clin 51 Oral Solution 51 Altabax 51 etanercept Enbrel 51 NitroMist TM 51 bazedoxifene 51 Indomethacin 51 onabotulinumtoxinA 51 ABILIFY R 51 VISICOL R 51 Torisel 51 Cladribine 51 Pregnancy Linked 51 FDA CDER 51 Pfizer maraviroc 51 albiglutide 51 Weight Loss Drug 51 Roche PEGASYS R 51 Wound Dressing 51 Oncology Drug 51 Saquinavir 51 Firazyr 51 PharmaVitae Profile 51 Keppra ® levetiracetam 51 naproxen esomeprazole magnesium 51 Mouse Model